These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9259400)

  • 21. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paediatric Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections.
    Santón A; Martín C; Manzanal AI; Preciado MV; Bellas C
    Br J Haematol; 1998 Oct; 103(1):129-36. PubMed ID: 9792299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
    Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
    Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations.
    Chu PG; Chang KL; Chen WG; Chen YY; Shibata D; Hayashi K; Bacchi C; Bacchi M; Weiss LM
    Am J Pathol; 1999 Sep; 155(3):941-7. PubMed ID: 10487851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
    Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
    Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
    Khanna R; Burrows SR; Moss DJ; Silins SL
    J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
    Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
    J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease.
    Preciado MV; De Matteo E; Diez B; Menárguez J; Grinstein S
    Blood; 1995 Nov; 86(10):3922-9. PubMed ID: 7579362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
    Kordek R; Biernat W; Kupnicka D; Woźniak L
    Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis.
    Sandvej KB; Hamilton-Dutoit SJ; Pallesen G
    Leuk Lymphoma; 1993 Jan; 9(1-2):95-101. PubMed ID: 7682882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    Lee SP; Thomas WA; Murray RJ; Khanim F; Kaur S; Young LS; Rowe M; Kurilla M; Rickinson AB
    J Virol; 1993 Dec; 67(12):7428-35. PubMed ID: 7693972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
    Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
    Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease.
    van Gorp J; Jacobse KC; Broekhuizen R; Alers J; van den Tweel JG; de Weger RA
    J Clin Pathol; 1994 Jan; 47(1):29-32. PubMed ID: 8132805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease.
    Enblad G; Sandvej K; Lennette E; Sundström C; Klein G; Glimelius B; Pallesen G
    Int J Cancer; 1997 Jul; 72(3):394-7. PubMed ID: 9247279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.
    Carbone A; Gloghini A; Zanette I; Canal B; Rizzo A; Volpe R
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):39-45. PubMed ID: 7679848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletions within the epstein-barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin's disease.
    Santón A; Bellas C
    Leuk Lymphoma; 2001 Jan; 40(3-4):235-42. PubMed ID: 11426545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders.
    Schwaller J; Tobler A; Niklaus G; Hurwitz N; Hennig I; Fey MF; Borisch B
    Blood; 1995 Apr; 85(8):2182-8. PubMed ID: 7718889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease.
    Armstrong AA; Gallagher A; Krajewski AS; Jones DB; Wilkins BS; Onions DE; Jarrett RF
    Histopathology; 1992 Jul; 21(1):72-3. PubMed ID: 1321789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.